Table 2 Imaging findings of patients with COVID-19
From: Analysis of 4 imaging features in patients with COVID-19
| Patients (n=34) | |
|---|---|
| Area of lession | |
| Unilateral lung | 11(32.4%) |
| Bilateral lung | 23(67.6%) |
| Number of lession | |
| single lession | 10(29.4%) |
| Multiple lessions | 24(70.6%) |
| Lobe of lesion distribution | |
| Multiple lobes | 19(55.9%) |
| Two lobes | 4(11.8%) |
| One lobe | 11(32.3%) |
| Vascular thickening | |
| Yes | 29(85.3%) |
| None | 5(14.7%) |
| Air bronchogram sign | |
| Yes | 16(47.1%) |
| None | 18(52.9%) |
| GGO | |
| Yes | 29(85.3%) |
| None | 5 (14.7%) |
| Pulmonary consolidation | |
| Yes | 8(23.5%) |
| None | 26(76.5%) |
| Pulmonary fibrosis | |
| Yes | 21(61.8%) |
| None | 13(38.2%) |
| Interlobular septal thickening | |
| Yes | 29(85.3%) |
| None | 5(14.7%) |
| “feathery sign” | |
| Yes | 22(65.2%) |
| None | 12 (34.8%) |
| “Dandelion sign” | |
| Yes | 18(52.9%) |
| None | 16(47.1%) |
| “Pomegranate sign” | |
| Yes | 9(26.1%) |
| None | 25(73.9.%) |
| “rime sign” | |
| Yes | 7(20.6%) |
| None | 27(79.4%) |
| Solid nodule | |
| Yes | 3(8.8%) |
| None | 31(91.2%) |
| Pleural effusion | |
| Yes | 1(2.9%) |
| None | 33(97.1%) |
| Mediastinal Lymphadenopathy | |
| Yes | 1(2.9%) |
| None | 33(97.1%) |